PT89041A - Purified hepatitis C virus - and associated nucleic acids and polypeptide(s) - Google Patents

Purified hepatitis C virus - and associated nucleic acids and polypeptide(s)

Info

Publication number
PT89041A
PT89041A PT8904188A PT8904188A PT89041A PT 89041 A PT89041 A PT 89041A PT 8904188 A PT8904188 A PT 8904188A PT 8904188 A PT8904188 A PT 8904188A PT 89041 A PT89041 A PT 89041A
Authority
PT
Portugal
Prior art keywords
virus
nucleic acids
hcv
polypeptide
associated nucleic
Prior art date
Application number
PT8904188A
Other languages
Portuguese (pt)
Other versions
PT89041B (en
Inventor
Michael Houghton
Qui-Lim Choo
George Kuo
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of PT89041A publication Critical patent/PT89041A/en
Publication of PT89041B publication Critical patent/PT89041B/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Purified hepatitis C virus (HCV) and purified or recombinant HCV nucleic acids and polypeptides are claimed. Also claimed are recombinant HCV nucleic acid vectors and expression systems, cells transformed with them, anti-HCV antibodies, and HCV-infected cells grown in tissue culture.
PT8904188A 1987-11-18 1988-11-18 METHOD OF PREPARATION OF NANBV DIAGNOSTICS AND VACCINES PT89041B (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12271487A 1987-11-18 1987-11-18
US13988687A 1987-12-30 1987-12-30
US16107288A 1988-02-26 1988-02-26
US19126388A 1988-05-06 1988-05-06
US27145088A 1988-11-14 1988-11-14

Publications (2)

Publication Number Publication Date
PT89041A true PT89041A (en) 1988-12-01
PT89041B PT89041B (en) 1993-03-31

Family

ID=27537645

Family Applications (1)

Application Number Title Priority Date Filing Date
PT8904188A PT89041B (en) 1987-11-18 1988-11-18 METHOD OF PREPARATION OF NANBV DIAGNOSTICS AND VACCINES

Country Status (2)

Country Link
IL (1) IL88420A (en)
PT (1) PT89041B (en)

Also Published As

Publication number Publication date
IL88420A (en) 2000-10-31
IL88420A0 (en) 1989-06-30
PT89041B (en) 1993-03-31

Similar Documents

Publication Publication Date Title
ATE229543T1 (en) POLYPEPTIDES OF HEPATITIS C VIRUS (HIV)
ATE224956T1 (en) METHOD FOR ENHANCED EXPRESSION OF VIRUS PROTEINS
OA07233A (en) Human immune interferon.
CY2053B1 (en) Synthetic antigens for the detection of antibodies to hepatitis c virus
AU8700291A (en) Hcv-specific peptides, agents therefor and the use thereof
AU2682388A (en) Diagnostic system
KR950704489A (en) INTERFERON TAU COMPOSITIONS AND METHODS OF USE
AU2197392A (en) Hepatitis C virus from C-100-3 and env/core regions
DE69310734D1 (en) PEPTID FOR THE STIMULATION OF CYTOTOIC T LYMPHOCYTES SPECIFIC FOR HEPATITIS C VIRUS
NO992158L (en) Nucleic acid and amino acid sequences associated with Heliobacter Pylori and vaccine preparations thereof.
PT89041A (en) Purified hepatitis C virus - and associated nucleic acids and polypeptide(s)
DK498387A (en) Viral DNA SEQUENCE
DE3885395D1 (en) Expression vector and method for the expression of heterologous proteins in mammalian cells.
DK123288A (en) PROCEDURE FOR INHIBITING RECOMBINANT HEPATITIS B SURFACE ANTIGEN
SU1380209A1 (en) RECOMBINANT PLASMID DNA PUR 291-HAV 22 ENCODING SYNTHESIS OF HYBRID POLYPEPTIDE OF HEPATITIS VIRUS A ANTIGENIC DETERMINANTS WITH β-GALACTOSIDASE
Zaslavsky Molecular biology of RNA animal viruses of agricultural importance and applied aspects in veterinary medicine. Part I. Picornaviruses.
NO306511B1 (en) Recombinant vector that selectively hybridizes to the genome of hepatitis C virus (HCV), a host cell transformed with the vector, and a method for producing a therapeutically active polypeptide
SG145521A1 (en) Synthetic antigens for the detection of antibodies to hepatitis c virus

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19920922

PD4A Change of proprietorship

Owner name: NOVARTIS VACCINES AND DIAGNOSTICS, INC., US

Effective date: 20080215

MM4A Annulment/lapse due to non-payment of fees;searched & examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20081118